SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-459919
Filing Date
2013-12-03
Accepted
2013-12-03 07:41:00
Documents
4
Period of Report
2013-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d637955d8k.htm 8-K 34800
2 EX-4.1 d637955dex41.htm EX-4.1 101191
3 EX-10.1 d637955dex101.htm EX-10.1 152064
4 EX-99.1 d637955dex991.htm EX-99.1 19028
  Complete submission text file 0001193125-13-459919.txt   308242
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 131253165
SIC: 2834 Pharmaceutical Preparations